NCT06681194View on ClinicalTrials.gov

Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Wound HealingGranulation Tissue
Interventions
DRUG

Silver Nitrate

"See Silver nitrate only study arm"

DRUG

triamcinolone

"See Triamcinolone only study arm"

DRUG

Silver nitrate + triamcinolone

"See Combination group study arm"

Trial Locations (1)

15213

UPMC Mercy Hospital, Pittsburgh

All Listed Sponsors
lead

Francesco Egro

OTHER

NCT06681194 - Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue | Biotech Hunter | Biotech Hunter